Smak Gregoor PJ, de Sévaux RG, Ligtenberg G, Hoitsma AJ, Hené RJ, Weimar W, et al
Although our understanding of the immunosuppressive mechanisms of these
Despite this improvement, however, patients treated with cyclosporine tend to have Objectives: We investigated the efficacy and safety of an immunosuppressive regimen consisting of tacrolimus or cyclosporine, with basiliximab, mycophenolate mofetil or
Source Reference: Schenk KM, et al "Nivolumab + tacrolimus + prednisone ± ipilimumab for kidney transplant recipients with advanced cutaneous cancers" J Clin
Background
In a randomized multicenter trial, 209 recipients of cadaveric renal transplants were treated either with cyclosporine and prednisone or with standard therapy that included